Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation.

Healey DCC, Cephus JY, Barone SM, Chowdhury NU, Dahunsi DO, Madden MZ, Ye X, Yu X, Olszewski K, Young K, Gerriets VA, Siska PJ, Dworski R, Hemler J, Locasale JW, Poyurovsky MV, Peebles RS, Irish JM, Newcomb DC, Rathmell JC
J Immunol. 2021 206 (6): 1127-1139

PMID: 33558372 · PMCID: PMC7946768 · DOI:10.4049/jimmunol.2001029

MeSH Terms (28)

Adult Alternaria Animals Asthma Biomarkers Blood Glucose Bronchoalveolar Lavage Fluid Case-Control Studies Cells, Cultured Dexamethasone Disease Models, Animal Drug Synergism Female Glucose Transporter Type 1 Glutaminase Glutamine Healthy Volunteers Humans Immunosuppressive Agents Lung Male Mice Middle Aged Primary Cell Culture Pyroglyphidae Th2 Cells Th17 Cells Young Adult

Connections (4)

This publication is referenced by other Labnodes entities: